Givinostat
Commons · Question 28286 · Tabled 3 Feb 2025 · Department of Health and Social Care · Official record
Answered 10 Feb 2025
Question
Asked by Martin Wrigley
To ask the Secretary of State for Health and Social Care, what steps he is taking to ensure access to Givinostat for families of children with Duchenne muscular dystrophy.
Answer
Answered by Karin Smyth, 10 Feb 2025
ITF Pharma UK, the United Kingdom marketing authorisation holder for givinostat, is providing access to givinostat through a type of compassionate use scheme called an Early Access Programme (EAP). Under the EAP, givinostat is free to both patients taking...